Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Acquires Fluo3 and Fluo4 Probe Lines from TEF Labs

NEW YORK (GenomeWeb News) - Invitrogen said yesterday that it has purchased two molecular probe product lines from TEF Labs.
 
The purchase gives Invitrogen TEF Labs' fluo3 and fluo4 product lines and all related intellectual property. Invitrogen's Molecular Probes business will assume the manufacture and sale of fluo 3 and fluo 4.
 
TEF Labs divested the product lines in order to "focus our resources on the development of new products and technologies," said Akwasi Minta, CEO of TEF Labs, in a statement.
 
Financial details were not disclosed.
 
The acquisition is Invitrogen's second announced this month. On Sept. 1, the company said that it plans to acquire 

cell-based assay company Sentigen Holding for around $25.9 million in cash

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.